The Efficacy and Mechanism Evaluation (EME) Programme: against COVID-19 Potential Funding Body

The Efficacy and Mechanism Evaluation (EME) Programme, which funds ambitious studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. Within these studies, EME supports research in the mechanisms of diseases and treatments. EME is a partnership between the Medical Research Council (MRC) and the NIHR. The EME Programme is funded by the Medical Research Council (MRC) and the NIHR, with contributions from the CSO in Scotland, Health and Care Research Wales and the HSC R&D Division, Public Health Agency in Northern Ireland.
It should be funding investigations related to COVID-19 and this is not the case.
https://www.nihr.ac.uk/explore-nihr/funding-programmes/efficacy-and-mechanism-evaluation.htm
Technology: COVID UK Funding&Support
Industry: COVID UK Government
Headquarters: United Kingdom
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: N/A

Visit Website
Register and Claim Ownership